• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Bets on new CEO





























Richard Francis ???

Let me understand this: Francis' Sandoz legacy before Vas Narasimham fired him: 5 years of lackluster no growth financial performance, squandered their biosimilar lead, messed up their US marketshare, and destroyed their competitiveness in manufacturing, while ballooning their Holzkirchen head office to over 1,000 people.

And Teva want this guy to come save them? Good luck!
 




Richard Francis ???

Let me understand this: Francis' Sandoz legacy before Vas Narasimham fired him: 5 years of lackluster no growth financial performance, squandered their biosimilar lead, messed up their US marketshare, and destroyed their competitiveness in manufacturing, while ballooning their Holzkirchen head office to over 1,000 people.

And Teva want this guy to come save them? Good luck!

Tell me again, what are we?